Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Claus Christiansen

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Concepts & Ideas

Disorders

Procedures

Physiology

Chemicals & Drugs

Anatomy

Bone and Bones

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
72
Hassager, C
51
Tanko, Laszlo
41
Alexandersen, Peter
34
Haarbo, Jens
33
Karsdal, Morten
31
Byrjalsen, Inger
29
Qvist, Per
28
Bjarnason, Nina
27
Bagger, Yu
23
Ravn, Pernille
21
Johansen, Julia
15
Schlemmer, A
13
Christgau, Stephan
12
Warming, Lise
11
Fledelius, C

Sign-in to see all Coauthors

Publications

TOP 3
Alexandersen Peter; Karsdal Morten A; Christiansen Claus
Long-term prevention with hormone-replacement therapy after the menopause: which women should be targeted?
Nielsen Mads; Raundahl Jakob; Pettersen Paola C; Loog Marco; Karemore Gopal; Karsdal Morten A; Christiansen Claus
Low-dose transdermal estradiol induces breast density and heterogeneity changes comparable to those of raloxifene.
Li Bo; Byrjalsen Inger; Glendenning Paul; Henriksen Dennis B; Hoeck Hans C; Taranto Mario; Vasikaran Samuel; Fraser William D; Christiansen Claus; Qvist Per
Selective monitoring of vitamin D2 and D3 supplementation with a highly specific 25-hydroxyvitamin D3 immunoassay with negligible cross-reactivity to 25-hydroxyvitamin D2.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Claus Christiansen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Alexandersen Peter; Karsdal Morten A; Christiansen Claus
Long-term prevention with hormone-replacement therapy after the menopause: which women should be targeted?
Women's health (London, England) 2009;5(6):637-47.
2009: Nielsen Mads; Raundahl Jakob; Pettersen Paola C; Loog Marco; Karemore Gopal; Karsdal Morten A; Christiansen Claus
Low-dose transdermal estradiol induces breast density and heterogeneity changes comparable to those of raloxifene.
Menopause (New York, N.Y.) 2009;16(4):785-91.
2009: Li Bo; Byrjalsen Inger; Glendenning Paul; Henriksen Dennis B; Hoeck Hans C; Taranto Mario; Vasikaran Samuel; Fraser William D; Christiansen Claus; Qvist Per
Selective monitoring of vitamin D2 and D3 supplementation with a highly specific 25-hydroxyvitamin D3 immunoassay with negligible cross-reactivity to 25-hydroxyvitamin D2.
Clinica chimica acta; international journal of clinical chemistry 2009;404(2):144-8.
2009: Rasmussen Henrik; Bagger Yu; Tanko Laszlo B; Christiansen Claus; Werge Thomas
Lack of association of the serotonin transporter gene promoter region polymorphism, 5-HTTLPR, including rs25531 with cigarette smoking and alcohol consumption.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2009;150B(4):575-80.
2009: Karsdal M A; Henriksen K; Leeming D J; Mitchell P; Duffin K; Barascuk N; Klickstein L; Aggarwal P; Nemirovskiy O; Byrjalsen I; Qvist P; Bay-Jensen A C; Dam E B; Madsen S H; Christiansen C
Biochemical markers and the FDA Critical Path: how biomarkers may contribute to the understanding of pathophysiology and provide unique and necessary tools for drug development.
Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 2009;14(3):181-202.
2009: Karsdal Morten A; Byrjalsen Inger; Azria Möise; Arnold Michel; Choi Les; Riis Bente J; Christiansen Claus
Influence of food intake on the bioavailability and efficacy of oral calcitonin.
British journal of clinical pharmacology 2009;67(4):413-20.
2009: Dam E B; Byrjalsen I; Karsdal M A; Qvist P; Christiansen C
Increased urinary excretion of C-telopeptides of type II collagen (CTX-II) predicts cartilage loss over 21 months by MRI.
Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society 2009;17(3):384-9.
2009: Karsdal Morten A; Byrjalsen Inger; Henriksen Kim; Riis Bente J; Christiansen Claus
A pharmacokinetic and pharmacodynamic comparison of synthetic and recombinant oral salmon calcitonin.
Journal of clinical pharmacology 2009;49(2):229-34.
2009: Bjarnason N H; Nielsen T F; Jørgensen H L; Christiansen C
The influence of smoking on bone loss and response to nasal estradiol.
Climacteric : the journal of the International Menopause Society 2009;12(1):59-65.
2009: Dam Erik B; Loog Marco; Christiansen Claus; Byrjalsen Inger; Folkesson Jenny; Nielsen Mads; Qazi Arish A; Pettersen Paola C; Garnero Patrick; Karsdal Morten A
Identification of progressors in osteoarthritis by combining biochemical and MRI-based markers.
Arthritis research & therapy 2009;11(4):R115.
2008: Marini Francesca; Falchetti Alberto; Silvestri Sandra; Bagger Yu; Luzi Ettore; Tanini Annalisa; Christiansen Claus; Brandi Maria Luisa
Modulatory effect of farnesyl pyrophosphate synthase (FDPS) rs2297480 polymorphism on the response to long-term amino-bisphosphonate treatment in postmenopausal osteoporosis.
Current medical research and opinion 2008;24(9):2609-15.
2008: Karsdal M A; Byrjalsen I; Leeming D J; Delmas P D; Christiansen C
The effects of oral calcitonin on bone collagen maturation: implications for bone turnover and quality.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2008;19(9):1355-61.
2008: Qvist Per; Bay-Jensen Anne-Christine; Christiansen Claus; Dam Erik B; Pastoureau Philippe; Karsdal Morten A
The disease modifying osteoarthritis drug (DMOAD): Is it in the horizon?
Pharmacological research : the official journal of the Italian Pharmacological Society 2008;58(1):1-7.
2008: Folkesson Jenny; Dam Erik B; Olsen Ole F; Karsdal Morten A; Pettersen Paola C; Christiansen Claus
Automatic quantification of local and global articular cartilage surface curvature: biomarkers for osteoarthritis?
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 2008;59(6):1340-6.
2008: Karsdal M A; Leeming D J; Dam E B; Henriksen K; Alexandersen P; Pastoureau P; Altman R D; Christiansen C
Should subchondral bone turnover be targeted when treating osteoarthritis?
Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society 2008;16(6):638-46.
2008: Pettersen P C; Raundahl J; Loog M; Nielsen M; Tankó L B; Christiansen C
Parallel assessment of the impact of different hormone replacement therapies on breast density by radiologist- and computer-based analyses of mammograms.
Climacteric : the journal of the International Menopause Society 2008;11(2):135-43.
2008: Byrjalsen I; Leeming D J; Qvist P; Christiansen C; Karsdal M A
Bone turnover and bone collagen maturation in osteoporosis: effects of antiresorptive therapies.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2008;19(3):339-48.
2008: Tankó L B; Søndergaard B-C; Oestergaard S; Karsdal M A; Christiansen C
An update review of cellular mechanisms conferring the indirect and direct effects of estrogen on articular cartilage.
Climacteric : the journal of the International Menopause Society 2008;11(1):4-16.
2008: Nielsen Rasmus H; Stoop Reinout; Leeming Diana J; Stolina Marina; Qvist Per; Christiansen Claus; Karsdal Morten A
Evaluation of cartilage damage by measuring collagen degradation products in joint extracts in a traumatic model of osteoarthritis.
Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 2008;13(1):79-87.
2008: Togsverd Mads; Werge Thomas M; Tankó Laszlo B; Bagger Yu Z; Hansen Thomas; Qin Gerong; Christiansen Claus; Rasmussen Henrik B
Association of a dopamine beta-hydroxylase gene variant with depression in elderly women possibly reflecting noradrenergic dysfunction.
Journal of affective disorders 2008;106(1-2):169-72.
2008: Karsdal Morten A; Madsen Suzi H; Christiansen Claus; Henriksen Kim; Fosang Amanda J; Sondergaard Bodil C
Cartilage degradation is fully reversible in the presence of aggrecanase but not matrix metalloproteinase activity.
Arthritis research & therapy 2008;10(3):R63.
2007: Bjarnason N H; Jorgensen H L; Byrjalsen I; Alexandersen P; Christiansen C
The influence of smoking on uterine bleeding during continuous and interrupted oral hormone therapy.
Climacteric : the journal of the International Menopause Society 2007;10(6):480-90.
2007: Karsdal Morten A; Sondergaard Bodil C; Arnold Michel; Christiansen Claus
Calcitonin affects both bone and cartilage: a dual action treatment for osteoarthritis?
Annals of the New York Academy of Sciences 2007;1117():181-95.
2007: Pettersen P C; de Bruijne M; Chen J; He Q; Christiansen C; Tankó L B
A computer-based measure of irregularity in vertebral alignment is a BMD-independent predictor of fracture risk in postmenopausal women.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2007;18(11):1525-30.
2007: Folkesson Jenny; Dam Erik B; Olsen Ole F; Christiansen Claus
Accuracy evaluation of automatic quantification of the articular cartilage surface curvature from MRI.
Academic radiology 2007;14(10):1221-8.
2007: Qazi Arish A; Dam Erik B; Nielsen Mads; Karsdal Morten A; Pettersen Paola C; Christiansen Claus
Osteoarthritic cartilage is more homogeneous than healthy cartilage: identification of a superior region of interest colocalized with a major risk factor for osteoarthritis.
Academic radiology 2007;14(10):1209-20.
2007: Qazi A A; Folkesson J; Pettersen P C; Karsdal M A; Christiansen C; Dam E B
Separation of healthy and early osteoarthritis by automatic quantification of cartilage homogeneity.
Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society 2007;15(10):1199-206.
2007: Togsverd Mads; Werge Thomas M; Tankó Laszlo B; Bagger Yu Z; Qin George G; Hansen Thomas; Christiansen Claus; Rasmussen Henrik B
Cognitive performance in elderly women: significance of the 19bp insertion/deletion polymorphism in the 5' flank of the dopamine beta-hydroxylase gene, educational level, body fat measures, serum triglyceride, alcohol consumption and age.
International journal of geriatric psychiatry 2007;22(9):883-9.
2007: Sondergaard Bodil-Cecilie; Oestergaard Svetlana; Christiansen Claus; Tankó Laszló B; Karsdal Morten Asser
The effect of oral calcitonin on cartilage turnover and surface erosion in an ovariectomized rat model.
Arthritis and rheumatism 2007;56(8):2674-8.
2007: Dam E B; Folkesson J; Pettersen P C; Christiansen C
Automatic morphometric cartilage quantification in the medial tibial plateau from MRI for osteoarthritis grading.
Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society 2007;15(7):808-18.
2007: Henriksen K; Leeming D J; Byrjalsen I; Nielsen R H; Sorensen M G; Dziegiel M H; Martin T John; Christiansen C; Qvist P; Karsdal M A
Osteoclasts prefer aged bone.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2007;18(6):751-9.
2007: Karsdal Morten Asser; Sumer Eren Ufuk; Wulf Helle; Madsen Suzi H; Christiansen Claus; Fosang Amanda J; Sondergaard Bodil-Cecilie
Induction of increased cAMP levels in articular chondrocytes blocks matrix metalloproteinase-mediated cartilage degradation, but not aggrecanase-mediated cartilage degradation.
Arthritis and rheumatism 2007;56(5):1549-58.
2007: Henriksen K; Tanko L B; Qvist P; Delmas P D; Christiansen C; Karsdal M A
Assessment of osteoclast number and function: application in the development of new and improved treatment modalities for bone diseases.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2007;18(5):681-5.
2007: Bjarnason N H; Byrjalsen I; Jørgensen H L; Christiansen C
The influence of smoking on uterine bleeding during sequential oral hormone therapy.
Climacteric : the journal of the International Menopause Society 2007;10(2):147-54.
2007: Fairbrother Una L; Tankó László B; Walley Andrew J; Christiansen Claus; Froguel Philippe; Blakemore Alexandra I F
Leptin receptor genotype at Gln223Arg is associated with body composition, BMD, and vertebral fracture in postmenopausal Danish women.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2007;22(4):544-50.
2007: Bagger Y Z; Rasmussen H B; Alexandersen P; Werge T; Christiansen C; Tankó L B;
Links between cardiovascular disease and osteoporosis in postmenopausal women: serum lipids or atherosclerosis per se?
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2007;18(4):505-12.
2007: Henriksen Dennis B; Alexandersen Peter; Hartmann Bolette; Adrian Charlotte L; Byrjalsen Inger; Bone Henry G; Holst Jens J; Christiansen Claus
Disassociation of bone resorption and formation by GLP-2: a 14-day study in healthy postmenopausal women.
Bone 2007;40(3):723-9.
2007: Olsen A K; Sondergaard B C; Byrjalsen I; Tanko L B; Christiansen C; Müller A; Hein G E; Karsdal M A; Qvist P
Anabolic and catabolic function of chondrocyte ex vivo is reflected by the metabolic processing of type II collagen.
Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society 2007;15(3):335-42.
2007: Sumer E U; Sondergaard B C; Rousseau J C; Delmas P D; Fosang A J; Karsdal M A; Christiansen C; Qvist P
MMP and non-MMP-mediated release of aggrecan and its fragments from articular cartilage: a comparative study of three different aggrecan and glycosaminoglycan assays.
Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society 2007;15(2):212-21.
2007: Folkesson Jenny; Dam Erik B; Olsen Ole F; Pettersen Paola C; Christiansen Claus
Segmenting articular cartilage automatically using a voxel classification approach.
IEEE transactions on medical imaging 2007;26(1):106-15.
2007: Conrad-Hansen Lars A; de Bruijne Marleen; Lauze François; Tankó László B; Pettersen Paola C; He Qing; Chen Jianghong; Christiansen Claus; Nielsen Mads
Quantifying calcification in the lumbar aorta on X-ray images.
Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention 2007;10(Pt 2):352-9.
2006: Tankó László B; Karsdal Morten A; Christiansen Claus; Leeming Diana J
Biochemical approach to the detection and monitoring of metastatic bone disease: What do we know and what questions need answers?
Cancer metastasis reviews 2006;25(4):659-68.
2006: Alexandersen Peter; Tankó László B; Bagger Yu Z; Jespersen Jørgen; Skouby Sven O; Christiansen Claus
Associations between aortic calcification and components of body composition in elderly men.
Obesity (Silver Spring, Md.) 2006;14(9):1571-8.
2006: Oestergaard Svetlana; Sondergaard Bodil C; Hoegh-Andersen Pernille; Henriksen Kim; Qvist Per; Christiansen Claus; Tankó László B; Karsdal Morten A
Effects of ovariectomy and estrogen therapy on type II collagen degradation and structural integrity of articular cartilage in rats: implications of the time of initiation.
Arthritis and rheumatism 2006;54(8):2441-51.
2006: Sondergaard B C; Henriksen K; Wulf H; Oestergaard S; Schurigt U; Bräuer R; Danielsen I; Christiansen C; Qvist P; Karsdal M A
Relative contribution of matrix metalloprotease and cysteine protease activities to cytokine-stimulated articular cartilage degradation.
Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society 2006;14(8):738-48.
2006: Sondergaard B C; Wulf H; Henriksen K; Schaller S; Oestergaard S; Qvist P; Tankó L B; Bagger Y Z; Christiansen C; Karsdal M A
Calcitonin directly attenuates collagen type II degradation by inhibition of matrix metalloproteinase expression and activity in articular chondrocytes.
Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society 2006;14(8):759-68.
2006: Karsdal M A; Tanko L B; Riis B J; Sondergard B C; Henriksen K; Altman R D; Qvist P; Christiansen C
Calcitonin is involved in cartilage homeostasis: is calcitonin a treatment for OA?
Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society 2006;14(7):617-24.
2006: Rasmussen Henrik Berg; Bagger Yu Z; Tankó László B; Qin Gerong; Christiansen Claus; Werge Thomas
Cognitive impairment in elderly women: the relative importance of selected genes, lifestyle factors, and comorbidities.
Neuropsychiatric disease and treatment 2006;2(2):227-33.
2006: Tankó L B; Christiansen C
Adipose tissue, insulin resistance and low-grade inflammation: implications for atherogenesis and the cardiovascular harm of estrogen plus progestogen therapy.
Climacteric : the journal of the International Menopause Society 2006;9(3):169-80.
2006: Delmas Pierre D; Adami Silvano; Strugala Cezary; Stakkestad Jacob A; Reginster Jean-Yves; Felsenberg Dieter; Christiansen Claus; Civitelli Roberto; Drezner Marc K; Recker Robert R; Bolognese Michael; Hughes Claire; Masanauskaite Daiva; Ward Penelope; Sambrook Philip; Reid David M
Intravenous ibandronate injections in postmenopausal women with osteoporosis: one-year results from the dosing intravenous administration study.
Arthritis and rheumatism 2006;54(6):1838-46.
2006: Bagger Y Z; Tankó L B; Alexandersen P; Qin G; Christiansen C;
Radiographic measure of aorta calcification is a site-specific predictor of bone loss and fracture risk at the hip.
Journal of internal medicine 2006;259(6):598-605.
2006: Silvestri Sandra; Thomsen Anne Bloch; Gozzini Alessia; Bagger Yu; Christiansen Claus; Brandi Maria Luisa
Estrogen receptor alpha and beta polymorphisms: is there an association with bone mineral density, plasma lipids, and response to postmenopausal hormone therapy?
Menopause (New York, N.Y.) 2006;13(3):451-61.
2006: Alexandersen P; Tankó L B; Bagger Y Z; Qin G; Christiansen C
The long-term impact of 2-3 years of hormone replacement therapy on cardiovascular mortality and atherosclerosis in healthy women.
Climacteric : the journal of the International Menopause Society 2006;9(2):108-18.
2006: Olsen Line; Rasmussen Henrik B; Hansen Thomas; Bagger Yu Z; Tankó László B; Qin Gerong; Christiansen Claus; Werge Thomas
Estrogen receptor alpha and risk for cognitive impairment in postmenopausal women.
Psychiatric genetics 2006;16(2):85-8.
2006: Nielsen Therese F; Ravn Pernille; Pitkin Joan; Christiansen Claus
Pulsed estrogen therapy improves postmenopausal quality of life: a 2-year placebo-controlled study.
Maturitas 2006;53(2):184-90.
2006: Karsdal Morten A; Qvist Per; Christiansen Claus; Tankó László B
Optimising antiresorptive therapies in postmenopausal women: why do we need to give due consideration to the degree of suppression?
Drugs 2006;66(15):1909-18.
2006: Ravn Pernille; Nielsen Therese F; Christiansen Claus
What can be learned from the levormeloxifene experience?
Acta obstetricia et gynecologica Scandinavica 2006;85(2):135-42.
2006: Bagger Yu Z; Tankó László B; Alexandersen Peter; Hansen Henrik B; Qin Gerong; Christiansen Claus
The long-term predictive value of bone mineral density measurements for fracture risk is independent of the site of measurement and the age at diagnosis: results from the Prospective Epidemiological Risk Factors study.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2006;17(3):471-7.
2005: Tankó László B; Siddiq Afshan; Lecoeur Cécile; Larsen Philip J; Christiansen Claus; Walley Andrew; Froguel Philippe
ACDC/adiponectin and PPAR-gamma gene polymorphisms: implications for features of obesity.
Obesity research 2005;13(12):2113-21.
2005: Tankó L B; Christiansen C
Effects of 17beta-oestradiol plus different doses of drospirenone on adipose tissue, adiponectin and atherogenic metabolites in postmenopausal women.
Journal of internal medicine 2005;258(6):544-53.
2005: Tankó László B; Christiansen Claus; Cox David A; Geiger Mary Jane; McNabb Michelle A; Cummings Steven R
Relationship between osteoporosis and cardiovascular disease in postmenopausal women.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2005;20(11):1912-20.
2005: Christiansen C
Effects of drospirenone/estrogen combinations on bone metabolism.
Climacteric : the journal of the International Menopause Society 2005;8 Suppl 3():35-41.
2005: Bagger Yu Z; Tankó László B; Alexandersen Peter; Karsdal Morten A; Olson Melvin; Mindeholm Linda; Azria Moïse; Christiansen Claus
Oral salmon calcitonin induced suppression of urinary collagen type II degradation in postmenopausal women: a new potential treatment of osteoarthritis.
Bone 2005;37(3):425-30.
2005: Alexandersen Peter; de Terlizzi Francesca; Tankó Laszló B; Bagger Yu Z; Christiansen Claus
Comparison of quantitative ultrasound of the phalanges with conventional bone densitometry in healthy postmenopausal women.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2005;16(9):1071-8.
2005: Tankó László B; Karsdal Morten A; Christiansen Claus
The clinical potential of estrogen for the prevention of osteoarthritis: what is known and what needs to be done?
Women's health (London, England) 2005;1(1):125-32.
2005: Tankó László B; Bagger Yu Z; Qin Gerong; Alexandersen Peter; Larsen Philip J; Christiansen Claus
Enlarged waist combined with elevated triglycerides is a strong predictor of accelerated atherogenesis and related cardiovascular mortality in postmenopausal women.
Circulation 2005;111(15):1883-90.
2005: Karsdal Morten A; Henriksen Kim; Sørensen Mette G; Gram Jeppe; Schaller Sophie; Dziegiel Morten H; Heegaard Anne-Marie; Christophersen Palle; Martin Thomas J; Christiansen Claus; Bollerslev Jens
Acidification of the osteoclastic resorption compartment provides insight into the coupling of bone formation to bone resorption.
The American journal of pathology 2005;166(2):467-76.
2005: Warming L; Ravn P; Christiansen C
Levonorgestrel and 17beta-estradiol given transdermally for the prevention of postmenopausal osteoporosis.
Maturitas 2005;50(2):78-85.
2005: Tankó László B; Qin Gerong; Alexandersen Peter; Bagger Yu Z; Christiansen Claus
Effective doses of ibandronate do not influence the 3-year progression of aortic calcification in elderly osteoporotic women.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2005;16(2):184-90.
2005: Bagger Yu Z; Tankó László B; Alexandersen Peter; Qin Gerong; Christiansen Claus;
Early postmenopausal hormone therapy may prevent cognitive impairment later in life.
Menopause (New York, N.Y.) 2005;12(1):12-7.
2005: Folkesson Jenny; Dam Erik; Olsen Ole Fogh; Pettersen Paola; Christiansen Claus
Automatic segmentation of the articular cartilage in knee MRI using a hierarchical multi-class classification scheme.
Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention 2005;8(Pt 1):327-34.
2004: Bjarnason N H; Jørgensen C; Kremmer H; Alexandersen P; Christiansen C
Smoking reduces breast tenderness during oral estrogen-progestogen therapy.
Climacteric : the journal of the International Menopause Society 2004;7(4):390-6.
2004: Qvist P; Munk M; Hoyle N; Christiansen C
Serum and plasma fragments of C-telopeptides of type I collagen (CTX) are stable during storage at low temperatures for 3 years.
Clinica chimica acta; international journal of clinical chemistry 2004;350(1-2):167-73.
2004: Ravn Pernille; Warming Lise; Christgau Stephan; Christiansen Claus
The effect on cartilage of different forms of application of postmenopausal estrogen therapy: comparison of oral and transdermal therapy.
Bone 2004;35(5):1216-21.
2004: Tankó László B; Bruun Jens M; Alexandersen Peter; Bagger Yu Z; Richelsen Bjørn; Christiansen Claus; Larsen Philip J
Novel associations between bioavailable estradiol and adipokines in elderly women with different phenotypes of obesity: implications for atherogenesis.
Circulation 2004;110(15):2246-52.
2004: Delmas P D; Recker R R; Chesnut C H; Skag A; Stakkestad J A; Emkey R; Gilbride J; Schimmer R C; Christiansen C
Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2004;15(10):792-8.
2004: Bagger Yu Z; Tankó László B; Alexandersen Peter; Qin Gerong; Christiansen Claus
The implications of body fat mass and fat distribution for cognitive function in elderly women.
Obesity research 2004;12(9):1519-26.
2004: Christgau Stephan; Tankó László B; Cloos Paul A C; Mouritzen Ulrik; Christiansen Claus; Delaissé Jean-Marie; Høegh-Andersen Pernille
Suppression of elevated cartilage turnover in postmenopausal women and in ovariectomized rats by estrogen and a selective estrogen-receptor modulator (SERM).
Menopause (New York, N.Y.) 2004;11(5):508-18.
2004: Tankó László B; Bagger Yu Z; Alexandersen Peter; Devogelaer Jean-Pierre; Reginster Jean-Yves; Chick Rosalind; Olson Melvin; Benmammar Hakim; Mindeholm Linda; Azria Moise; Christiansen Claus
Safety and efficacy of a novel salmon calcitonin (sCT) technology-based oral formulation in healthy postmenopausal women: acute and 3-month effects on biomarkers of bone turnover.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2004;19(9):1531-8.
2004: Chesnut III Charles H; Skag Arne; Christiansen Claus; Recker Robert; Stakkestad Jacob A; Hoiseth Arne; Felsenberg Dieter; Huss Hermann; Gilbride Jennifer; Schimmer Ralph C; Delmas Pierre D;
Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2004;19(8):1241-9.
2004: Warming Lise; Ravn Pernille; Spielman Danièle; Delmas Pierre; Christiansen Claus
Trimegestone in a low-dose, continuous-combined hormone therapy regimen prevents bone loss in osteopenic postmenopausal women.
Menopause (New York, N.Y.) 2004;11(3):337-42.
2004: Recker R; Stakkestad J A; Chesnut C H; Christiansen C; Skag A; Hoiseth A; Ettinger M; Mahoney P; Schimmer R C; Delmas P D
Insufficiently dosed intravenous ibandronate injections are associated with suboptimal antifracture efficacy in postmenopausal osteoporosis.
Bone 2004;34(5):890-9.
2004: Adami S; Felsenberg D; Christiansen C; Robinson J; Lorenc R S; Mahoney P; Coutant K; Schimmer R C; Delmas P D
Efficacy and safety of ibandronate given by intravenous injection once every 3 months.
Bone 2004;34(5):881-9.
2004: Bagger Yu Z; Tankó László B; Alexandersen Peter; Hansen Henrik Bo; Møllgaard Anette; Ravn Pernille; Qvist Per; Kanis John A; Christiansen Claus
Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: the PERF study.
Bone 2004;34(4):728-35.
2004: Warming L; Ravn P; Nielsen T; Christiansen C
Safety and efficacy of drospirenone used in a continuous combination with 17beta-estradiol for prevention of postmenopausal osteoporosis.
Climacteric : the journal of the International Menopause Society 2004;7(1):103-11.
2004: Nielsen Therese F; Ravn Pernille; Bagger Yu Z; Warming Lise; Christiansen Claus
Pulsed estrogen therapy in prevention of postmenopausal osteoporosis. A 2-year randomized, double blind, placebo-controlled study.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2004;15(2):168-74.
2004: Henriksen Dennis B; Alexandersen Peter; Byrjalsen Inger; Hartmann Bolette; Bone Henry G; Christiansen Claus; Holst Jens Juul
Reduction of nocturnal rise in bone resorption by subcutaneous GLP-2.
Bone 2004;34(1):140-7.
2004: Tankó László B; Christiansen Claus
An update on the antiestrogenic effect of smoking: a literature review with implications for researchers and practitioners.
Menopause (New York, N.Y.) 2004;11(1):104-9.
2004: Thomsen Anne Bloch; Silvestri Sandra; Haarbo Jens; Christiansen Claus; Bjarnason Nina H
Associated response in bone and lipids during hormone replacement therapy.
Maturitas 2004;47(1):39-45.
2004: Cloos Paul A C; Lyubimova Nina; Solberg Helene; Qvist Per; Christiansen Claus; Byrjalsen Inger; Christgau Stephan
An immunoassay for measuring fragments of newly synthesized collagen type I produced during metastatic invasion of bone.
Clinical laboratory 2004;50(5-6):279-89.
2003: Henriksen Dennis B; Alexandersen Peter; Bjarnason Nina H; Vilsbøll Tina; Hartmann Bolette; Henriksen Eva E G; Byrjalsen Inger; Krarup Thure; Holst Jens J; Christiansen Claus
Role of gastrointestinal hormones in postprandial reduction of bone resorption.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2003;18(12):2180-9.
2003: Bagger Yu Z; Tankó László B; Alexandersen Peter; Ravn Pernille; Christiansen Claus
Alendronate has a residual effect on bone mass in postmenopausal Danish women up to 7 years after treatment withdrawal.
Bone 2003;33(3):301-7.
2003: Tankó László B; Bagger Yu Z; Alexandersen Peter; Larsen Philip J; Christiansen Claus
Central and peripheral fat mass have contrasting effect on the progression of aortic calcification in postmenopausal women.
European heart journal 2003;24(16):1531-7.
2003: Tankó L B; Felsenberg D; Czerwinski E; Burdeska A; Jonkanski I; Hughes C; Christiansen C;
Oral weekly ibandronate prevents bone loss in postmenopausal women.
Journal of internal medicine 2003;254(2):159-67.
2003: Ravn P; Thompson Desmond E; Ross Philip D; Christiansen C
Biochemical markers for prediction of 4-year response in bone mass during bisphosphonate treatment for prevention of postmenopausal osteoporosis.
Bone 2003;33(1):150-8.
2003: Alexandersen Peter; Haarbo Jens; Zandberg Pieter; Jespersen Jørgen; Skouby Sven O; Christiansen Claus
Lack of difference among progestins on the anti-atherogenic effect of ethinyl estradiol: a rabbit study.
Human reproduction (Oxford, England) 2003;18(7):1395-403.
2003: Christiansen C; Tankó L B; Warming L; Moelgaard A; Christgau S; Qvist P; Baumann M; Wieczorek L; Hoyle N
Dose dependent effects on bone resorption and formation of intermittently administered intravenous ibandronate.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2003;14(7):609-13.
2003: Bloch-Thomsen A; Silvestri S; Christiansen C; Bjarnason N H
Associated response in bone mineral density and atherogenic lipid profile during treatment with two different selective estrogen receptor modulators: levormeloxifene and raloxifene.
Climacteric : the journal of the International Menopause Society 2003;6(2):159-67.
2003: Tankó L B; Mouritzen U; Lehmann H J; Warming L; Moelgaard A; Christgau S; Qvist P; Baumann M; Wieczorek L; Hoyle N; Christiansen C
Oral ibandronate: changes in markers of bone turnover during adequately dosed continuous and weekly therapy and during different suboptimally dosed treatment regimens.
Bone 2003;32(6):687-93.
2003: Movsesyan Lusine; Tankó László B; Larsen Philip J; Christiansen Claus; Svendsen Ole L
Variations in percentage of body fat within different BMI groups in young, middle-aged and old women.
Clinical physiology and functional imaging 2003;23(3):130-3.
2003: Tankó L B; McClung M R; Schimmer R C; Mahoney P; Christiansen C
The efficacy of 48-week oral ibandronate treatment in postmenopausal osteoporosis when taken 30 versus 60 minutes before breakfast.
Bone 2003;32(4):421-6.
2003: Tankó László B; Bagger Yu Z; Alexandersen Peter; Larsen Philip J; Christiansen Claus
Peripheral adiposity exhibits an independent dominant antiatherogenic effect in elderly women.
Circulation 2003;107(12):1626-31.
2003: Mouritzen U; Christgau S; Lehmann H-J; Tankó L B; Christiansen C
Cartilage turnover assessed with a newly developed assay measuring collagen type II degradation products: influence of age, sex, menopause, hormone replacement therapy, and body mass index.
Annals of the rheumatic diseases 2003;62(4):332-6.
2003: Warming L; Christoffersen C; Riis B J; Stakkestad J A; Delmas P D; Christiansen C
Adverse effects of a SERM (Levormeloxifene). Safety parameters and bone mineral density 12 months after treatment withdrawal.
Maturitas 2003;44(3):189-99.
2003: Warming Lise; Ravn Pernille; Christiansen Claus
Visceral fat is more important than peripheral fat for endometrial thickness and bone mass in healthy postmenopausal women.
American journal of obstetrics and gynecology 2003;188(2):349-53.
2003: Cloos P A C; Fledelius C; Christgau S; Christiansen C; Engsig M; Delmas P; Body J-J; Garnero P
Investigation of bone disease using isomerized and racemized fragments of type I collagen.
Calcified tissue international 2003;72(1):8-17.
2003: Cloos Paul Andreas Compare; Christgau Stephan; Lyubimova Nina; Body Jean-Jacques; Qvist Per; Christiansen Claus
Breast cancer patients with bone metastases are characterised by increased levels of nonisomerised type I collagen fragments.
Breast cancer research : BCR 2003;5(4):R103-9.
2002: Warming L; Ravn P; Skouby S; Christiansen C
Measurement precision and normal range of endometrial thickness in a postmenopausal population by transvaginal ultrasound.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2002;20(5):492-5.
2002: Riis Bente Juel; Lehmann Hans-Jørgen; Christiansen Claus
Norethisterone acetate in combination with estrogen: effects on the skeleton and other organs. A review.
American journal of obstetrics and gynecology 2002;187(4):1101-16.
2002: Qvist P; Christgau S; Pedersen B J; Schlemmer A; Christiansen C
Circadian variation in the serum concentration of C-terminal telopeptide of type I collagen (serum CTx): effects of gender, age, menopausal status, posture, daylight, serum cortisol, and fasting.
Bone 2002;31(1):57-61.
2002: Lehmann H J; Mouritzen U; Christgau S; Cloos P A C; Christiansen C
Effect of bisphosphonates on cartilage turnover assessed with a newly developed assay for collagen type II degradation products.
Annals of the rheumatic diseases 2002;61(6):530-3.
2002: Tankó László B; Warming Lise; Bagger Yu Z; Byrjalsen Inger; Jensen Susi; Christiansen Claus
Serum placental protein 14: a novel marker of selective oestrogen receptor modulator action on the postmenopausal endometrium.
Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 2002;7(3):257-66.
2002: Bjarnason N H; Alexandersen P; Christiansen C
Number of years since menopause: spontaneous bone loss is dependent but response to hormone replacement therapy is independent.
Bone 2002;30(4):637-42.
2002: Tankó László B; Movsesyan Lusine; Svendsen Ole L; Christiansen Claus
The effect of hormone replacement therapy on appendicular lean tissue mass in early postmenopausal women.
Menopause (New York, N.Y.) 2002;9(2):117-21.
2002: Ravn P; Neugebauer G; Christiansen C
Association between pharmacokinetics of oral ibandronate and clinical response in bone mass and bone turnover in women with postmenopausal osteoporosis.
Bone 2002;30(1):320-4.
2002: Bjarnason N H; Henriksen E E G; Alexandersen P; Christgau S; Henriksen D B; Christiansen C
Mechanism of circadian variation in bone resorption.
Bone 2002;30(1):307-13.
2002: Tankó László B; Movsesyan Lusine; Mouritzen Ulrik; Christiansen Claus; Svendsen Ole L
Appendicular lean tissue mass and the prevalence of sarcopenia among healthy women.
Metabolism: clinical and experimental 2002;51(1):69-74.
2002: Warming L; Hassager C; Christiansen C
Changes in bone mineral density with age in men and women: a longitudinal study.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2002;13(2):105-12.
2001: Riis B J; Ise J; von Stein T; Bagger Y; Christiansen C
Ibandronate: a comparison of oral daily dosing versus intermittent dosing in postmenopausal osteoporosis.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2001;16(10):1871-8.
2001: Alexandersen P; Hassager C; Christiansen C
Influence of female and male sex steroids on body composition in the rabbit model.
Climacteric : the journal of the International Menopause Society 2001;4(3):219-27.
2001: Alexandersen P; Haarbo J; Breinholt V; Christiansen C
Dietary phytoestrogens and estrogen inhibit experimental atherosclerosis.
Climacteric : the journal of the International Menopause Society 2001;4(2):151-9.
2001: Christiansen C
Hormone replacement therapy for the postmenopausal woman.
Maturitas 2001;38 Suppl 1():S1-5.
2001: Alexandersen P; Toussaint A; Christiansen C; Devogelaer J P; Roux C; Fechtenbaum J; Gennari C; Reginster J Y;
Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2001;285(11):1482-8.
2001: Alexandersen P; Riis B J; Stakkestad J A; Delmas P D; Christiansen C
Efficacy of levormeloxifene in the prevention of postmenopausal bone loss and on the lipid profile compared to low dose hormone replacement therapy.
The Journal of clinical endocrinology and metabolism 2001;86(2):755-60.
2001: Bjarnason N H; Haarbo J; Byrjalsen I; Alexandersen P; Kauffman R F; Christiansen C
Raloxifene and estrogen reduces progression of advanced atherosclerosis--a study in ovariectomized, cholesterol-fed rabbits.
Atherosclerosis 2001;154(1):97-102.
2001: Bjarnason N H; Sarkar S; Duong T; Mitlak B; Delmas P D; Christiansen C
Six and twelve month changes in bone turnover are related to reduction in vertebral fracture risk during 3 years of raloxifene treatment in postmenopausal osteoporosis.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2001;12(11):922-30.
2001: Bjarnason N H; Riis B J; Christiansen C
The effect of fluvastatin on parameters of bone remodeling.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2001;12(5):380-4.
2000: Johnston C C; Bjarnason N H; Cohen F J; Shah A; Lindsay R; Mitlak B H; Huster W; Draper M W; Harper K D; Heath H; Gennari C; Christiansen C; Arnaud C D; Delmas P D
Long-term effects of raloxifene on bone mineral density, bone turnover, and serum lipid levels in early postmenopausal women: three-year data from 2 double-blind, randomized, placebo-controlled trials.
Archives of internal medicine 2000;160(22):3444-50.
2000: Bjarnason N H; Byrjalsen I; Hassager C; Haarbo J; Christiansen C
Low doses of estradiol in combination with gestodene to prevent early postmenopausal bone loss.
American journal of obstetrics and gynecology 2000;183(3):550-60.
2000: Bagger Y Z; Hassager C; Heegaard A M; Christiansen C
Vitamin D receptor and estrogen receptor gene polymorphisms in postmenopausal Danish women: no relation to bone markers or serum lipoproteins.
Climacteric : the journal of the International Menopause Society 2000;3(2):84-91.
2000: Bjarnason N H; Christiansen C
Early response in biochemical markers predicts long-term response in bone mass during hormone replacement therapy in early postmenopausal women.
Bone 2000;26(6):561-9.
2000: Alexandersen P; Byrjalsen I; Christiansen C
Piperazine oestrone sulphate and interrupted norethisterone in postmenopausal women: effects on bone mass, lipoprotein metabolism, climacteric symptoms, and adverse effects.
BJOG : an international journal of obstetrics and gynaecology 2000;107(3):356-64.
2000: Byrjalsen I; Alexandersen P; Christiansen C
Piperazine oestrone sulphate and interrupted norethisterone: effects on the postmenopausal endometrium.
BJOG : an international journal of obstetrics and gynaecology 2000;107(3):347-55.
2000: Bjarnason N H; Christiansen C
The influence of thinness and smoking on bone loss and response to hormone replacement therapy in early postmenopausal women.
The Journal of clinical endocrinology and metabolism 2000;85(2):590-6.
2000: Bjarnason N H; Haarbo J; Byrjalsen I; Kauffman R F; Knadler M P; Christiansen C
Raloxifene reduces atherosclerosis: studies of optimized raloxifene doses in ovariectomized, cholesterol-fed rabbits.
Clinical endocrinology 2000;52(2):225-33.
1999: Alexandersen P; Riis B J; Christiansen C
Monofluorophosphate combined with hormone replacement therapy induces a synergistic effect on bone mass by dissociating bone formation and resorption in postmenopausal women: a randomized study.
The Journal of clinical endocrinology and metabolism 1999;84(9):3013-20.
1999: Ravn P; Cizza G; Bjarnason N H; Thompson D; Daley M; Wasnich R D; McClung M; Hosking D; Yates A J; Christiansen C
Low body mass index is an important risk factor for low bone mass and increased bone loss in early postmenopausal women. Early Postmenopausal Intervention Cohort (EPIC) study group.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1999;14(9):1622-7.
1999: Ettinger B; Black D M; Mitlak B H; Knickerbocker R K; Nickelsen T; Genant H K; Christiansen C; Delmas P D; Zanchetta J R; Stakkestad J; Glüer C C; Krueger K; Cohen F J; Eckert S; Ensrud K E; Avioli L V; Lips P; Cummings S R
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators.
JAMA : the journal of the American Medical Association 1999;282(7):637-45.
1999: Ravn P; Hosking D; Thompson D; Cizza G; Wasnich R D; McClung M; Yates A J; Bjarnason N H; Christiansen C
Monitoring of alendronate treatment and prediction of effect on bone mass by biochemical markers in the early postmenopausal intervention cohort study.
The Journal of clinical endocrinology and metabolism 1999;84(7):2363-8.
1999: Alexandersen P; Haarbo J; Byrjalsen I; Lawaetz H; Christiansen C
Natural androgens inhibit male atherosclerosis: a study in castrated, cholesterol-fed rabbits.
Circulation research 1999;84(7):813-9.
1999: Byrjalsen I; Bjarnason N H; Christiansen C
Progestational effects of combinations of gestodene on the postmenopausal endometrium during hormone replacement therapy.
American journal of obstetrics and gynecology 1999;180(3 Pt 1):539-49.
1999: Ravn P; Clemmesen B; Christiansen C
Biochemical markers can predict the response in bone mass during alendronate treatment in early postmenopausal women. Alendronate Osteoporosis Prevention Study Group.
Bone 1999;24(3):237-44.
1999: Christiansen C
Sex steroid analogs.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 1999;9 Suppl 2():S62-5.
1998: Christgau S; Rosenquist C; Alexandersen P; Bjarnason N H; Ravn P; Fledelius C; Herling C; Qvist P; Christiansen C
Clinical evaluation of the Serum CrossLaps One Step ELISA, a new assay measuring the serum concentration of bone-derived degradation products of type I collagen C-telopeptides.
Clinical chemistry 1998;44(11):2290-300.
1998: Rosenquist C; Fledelius C; Christgau S; Pedersen B J; Bonde M; Qvist P; Christiansen C
Serum CrossLaps One Step ELISA. First application of monoclonal antibodies for measurement in serum of bone-related degradation products from C-terminal telopeptides of type I collagen.
Clinical chemistry 1998;44(11):2281-9.
1998: Alexandersen P; Haarbo J; Sandholdt I; Shalmi M; Lawaetz H; Christiansen C
Norethindrone acetate enhances the antiatherogenic effect of 17beta-estradiol: a secondary prevention study of aortic atherosclerosis in ovariectomized cholesterol-fed rabbits.
Arteriosclerosis, thrombosis, and vascular biology 1998;18(6):902-7.
1998: Jørgensen H L; Jørgensen L V; Hassager C; Møllgaard A; Christiansen C
Quantitative ultrasound (QUS) on a specific region of interest (ROI) of the Os calcis: a new imaging technique.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 1998;49(5-6):681-3.
1998: Hetland M L; Haarbo J; Christiansen C
Regional body composition determined by dual-energy X-ray absorptiometry. Relation to training, sex hormones, and serum lipids in male long-distance runners.
Scandinavian journal of medicine & science in sports 1998;8(2):102-8.
1998: Bjarnason N H; Hassager C; Christiansen C
Postmenopausal bone remodelling and hormone replacement.
Climacteric : the journal of the International Menopause Society 1998;1(1):72-9.
1998: Christensen J O; Svendsen O L; Hassager C; Christiansen C
Leptin in overweight postmenopausal women: no relationship with metabolic syndrome X or effect of exercise in addition to diet.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1998;22(3):195-9.
1998: Hosking D; Chilvers C E; Christiansen C; Ravn P; Wasnich R; Ross P; McClung M; Balske A; Thompson D; Daley M; Yates A J
Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group.
The New England journal of medicine 1998;338(8):485-92.
1998: Jørgensen H L; Schøller J; Sand J C; Bjuring M; Hassager C; Christiansen C
[Relation between common allelic variation in a cross-sectional longitudinal population study. Vitamin D receptor locus, bone mineral density and postmenopausal bone loss]
Ugeskrift for laeger 1998;160(5):648-53.
1998: Christiansen C
Practical application of risk assessment.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 1998;8 Suppl 1():S43-6.
1997: Delmas P D; Bjarnason N H; Mitlak B H; Ravoux A C; Shah A S; Huster W J; Draper M; Christiansen C
Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women.
The New England journal of medicine 1997;337(23):1641-7.
1997: Bjarnason N H; Haarbo J; Byrjalsen I; Kauffman R F; Christiansen C
Raloxifene inhibits aortic accumulation of cholesterol in ovariectomized, cholesterol-fed rabbits.
Circulation 1997;96(6):1964-9.
1997: Alexandersen P; Haarbo J; Christiansen C
Impact of combined hormone replacement therapy on serum lipid metabolism: new aspects.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 1997;11(4):281-8.
1997: Schlemmer A; Hassager C; Alexandersen P; Fledelius C; Pedersen B J; Kristensen I O; Christiansen C
Circadian variation in bone resorption is not related to serum cortisol.
Bone 1997;21(1):83-8.
1997: Bonde M; Garnero P; Fledelius C; Qvist P; Delmas P D; Christiansen C
Measurement of bone degradation products in serum using antibodies reactive with an isomerized form of an 8 amino acid sequence of the C-telopeptide of type I collagen.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1997;12(7):1028-34.
1997: Bjarnason N H; Bjarnason K; Haarbo J; Bennink H J; Christiansen C
Tibolone: influence on markers of cardiovascular disease.
The Journal of clinical endocrinology and metabolism 1997;82(6):1752-6.
1997: Fledelius C; Kolding I; Qvist P; Bonde M; Hassager C; Reginster J Y; Hejgaard J; Frøokiaer H; Christiansen C
Development of a monoclonal antibody to urinary degradation products from the C-terminal telopeptide alpha 1 chain of type I collagen. Application in an enzyme immunoassay and comparison to CrossLaps ELISA.
Scandinavian journal of clinical and laboratory investigation 1997;57(1):73-83.
1997: Bjarnason N H; Bjarnason K; Hassager C; Christiansen C
The response in spinal bone mass to tibolone treatment is related to bone turnover in elderly women.
Bone 1997;20(2):151-5.
1997: Schlemmer A; Ravn P; Hassager C; Christiansen C
Morning or evening administration of nasal calcitonin? Effects on biochemical markers of bone turnover.
Bone 1997;20(1):63-7.
1997: Christiansen C
The strategy for the treatment of osteoporosis.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 1997;7 Suppl 3():S147-9.
1997: Clemmesen B; Ravn P; Zegels B; Taquet A N; Christiansen C; Reginster J Y
A 2-year phase II study with 1-year of follow-up of risedronate (NE-58095) in postmenopausal osteoporosis.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 1997;7(5):488-95.
1997: Christiansen C
Sex steroids and the cardiovascular system.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 1997;7 Suppl 1():S8-11.
1996: Ravn P; Clemmesen B; Riis B J; Christiansen C
The effect on bone mass and bone markers of different doses of ibandronate: a new bisphosphonate for prevention and treatment of postmenopausal osteoporosis: a 1-year, randomized, double-blind, placebo-controlled dose-finding study.
Bone 1996;19(5):527-33.
1996: Bonde M; Fledelius C; Qvist P; Christiansen C
Coated-tube radioimmunoassay for C-telopeptides of type I collagen to assess bone resorption.
Clinical chemistry 1996;42(10):1639-44.
1996: Ravn P; Fledelius C; Rosenquist C; Overgaard K; Christiansen C
High bone turnover is associated with low bone mass in both pre- and postmenopausal women.
Bone 1996;19(3):291-8.
1996: Jørgensen H L; Schøller J; Sand J C; Bjuring M; Hassager C; Christiansen C
Relation of common allelic variation at vitamin D receptor locus to bone mineral density and postmenopausal bone loss: cross sectional and longitudinal population study.
BMJ (Clinical research ed.) 1996;313(7057):586-90.
1996: Alexandersen P; Haarbo J; Christiansen C
The relationship of natural androgens to coronary heart disease in males: a review.
Atherosclerosis 1996;125(1):1-13.
1996: Riis B J; Hansen M A; Jensen A M; Overgaard K; Christiansen C
Low bone mass and fast rate of bone loss at menopause: equal risk factors for future fracture: a 15-year follow-up study.
Bone 1996;19(1):9-12.
1996: Bjarnason N H; Bjarnason K; Haarbo J; Rosenquist C; Christiansen C
Tibolone: prevention of bone loss in late postmenopausal women.
The Journal of clinical endocrinology and metabolism 1996;81(7):2419-22.
1996: Overgaard K; Christiansen C
A new biochemical marker of bone resorption for follow-up on treatment with nasal salmon calcitonin.
Calcified tissue international 1996;59(1):12-6.
1996: Haarbo J; Christiansen C
The impact of female sex hormones on secondary prevention of atherosclerosis in ovariectomized cholesterol-fed rabbits.
Atherosclerosis 1996;123(1-2):139-44.
1996: Overgaard K; Alexandersen P; Riis B J; Christiansen C
Evaluation of a new commercial IRMA for bone-specific alkaline phosphatase during treatment with hormone replacement therapy and calcitonin.
Clinical chemistry 1996;42(6 Pt 1):973-4.
1996: Christiansen C
Hormone replacement therapy and osteoporosis.
Maturitas 1996;23 Suppl():S71-6.
1996: Jørgensen H L; Schøller J; Sand J C; Bjuring M; Hassager C; Christiansen C
Relationship of common allelic variation at the vitamin D receptor locus to bone mineral density and bone turnover.
British journal of obstetrics and gynaecology 1996;103 Suppl 13():28-30; discussion 30-1.
1996: Svendsen O L; Hassager C; Christiansen C; Nielsen J D; Winther K
Plasminogen activator inhibitor-1, tissue-type plasminogen activator, and fibrinogen: Effect of dieting with or without exercise in overweight postmenopausal women.
Arteriosclerosis, thrombosis, and vascular biology 1996;16(3):381-5.
1996: Wang Q; Ravn P; Wang S; Overgaard K; Hassager C; Christiansen C
Bone mineral density in immigrants from southern China to Denmark. A cross-sectional study.
European journal of endocrinology / European Federation of Endocrine Societies 1996;134(2):163-7.
1996: von der Recke P; Hansen M A; Overgaard K; Christiansen C
The impact of degenerative conditions in the spine on bone mineral density and fracture risk prediction.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 1996;6(1):43-9.
1996: Bjarnason K; Hassager C; Svendsen O L; Stang H; Christiansen C
Anteroposterior and lateral spinal DXA for the assessment of vertebral body strength: comparison with hip and forearm measurement.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 1996;6(1):37-42.
1995: Christiansen C
Osteoporosis: diagnosis and management today and tomorrow.
Bone 1995;17(5 Suppl):513S-516S.
1995: Byrjalsen I; Larsen P M; Fey S J; Christiansen C
Human endometrial proteins with cyclic changes in the expression during the normal menstrual cycle: characterization by protein sequence analysis.
Human reproduction (Oxford, England) 1995;10(10):2760-6.
1995: Rosenquist C; Qvist P; Bjarnason N; Christiansen C
Measurement of a more stable region of osteocalcin in serum by ELISA with two monoclonal antibodies.
Clinical chemistry 1995;41(10):1439-45.
1995: Hassager C; Wang Q; Christiansen C
Creatinine clearance at menopause is not related to bone mass in later life.
Maturitas 1995;22(2):131-6.
1995: Hetland M L; Haarbo J; Christiansen C
Body composition and serum lipids in female runners: influence of exercise level and menstrual bleeding pattern.
European journal of clinical investigation 1995;25(8):553-8.
1995: Overgaard K; Lindsay R; Christiansen C
Patient responsiveness to calcitonin salmon nasal spray: a subanalysis of a 2-year study.
Clinical therapeutics 1995;17(4):680-5.
1995: Svendsen O L; Hassager C; Christiansen C
The response to treatment of overweight in postmenopausal women is not related to fat distribution.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1995;19(7):496-502.
1995: Pedersen B J; Schlemmer A; Hassager C; Christiansen C
Changes in the carboxyl-terminal propeptide of type I procollagen and other markers of bone formation upon five days of bed rest.
Bone 1995;17(1):91-5.
1995: Svendsen O L; Hassager C; Skødt V; Christiansen C
Impact of soft tissue on in vivo accuracy of bone mineral measurements in the spine, hip, and forearm: a human cadaver study.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1995;10(6):868-73.
1995: Ravn P; Overgaard K; Spencer E M; Christiansen C
Insulin-like growth factors I and II in healthy women with and without established osteoporosis.
European journal of endocrinology / European Federation of Endocrine Societies 1995;132(3):313-9.
1995: Svendsen O L; Hassager C; Christiansen C
Age- and menopause-associated variations in body composition and fat distribution in healthy women as measured by dual-energy X-ray absorptiometry.
Metabolism: clinical and experimental 1995;44(3):369-73.
1995: Bonde M; Qvist P; Fledelius C; Riis B J; Christiansen C
Applications of an enzyme immunoassay for a new marker of bone resorption (CrossLaps): follow-up on hormone replacement therapy and osteoporosis risk assessment.
The Journal of clinical endocrinology and metabolism 1995;80(3):864-8.
1995: Bjarnason K; Nilas L; Hassager C; Christiansen C
Dual energy X-ray absorptiometry of the spine--decubitus lateral versus anteroposterior projection in osteoporotic women: comparison to single energy X-ray absorptiometry of the forearm.
Bone 1995;16(2):255-60.
1995: Hansen M A; Overgaard K; Christiansen C
Spontaneous postmenopausal bone loss in different skeletal areas--followed up for 15 years.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1995;10(2):205-10.
1995: Christiansen C
What should be done at the time of menopause?
The American journal of medicine 1995;98(2A):56S-59S.
1995: Byrjalsen I; Larsen P M; Fey S J; Thormann L; Pedersen B J; Christiansen C
Two-dimensional gel analysis of human endometrial proteins: cyclic changes in the expression of specific proteins during the normal menstrual cycle.
Human reproduction (Oxford, England) 1995;10(1):13-8.
1995: Bjarnason K; Hassager C; Ravn P; Christiansen C
Early postmenopausal diminution of forearm and spinal bone mineral density: a cross-sectional study.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 1995;5(1):35-8.
1995: Pedersen B J; Schlemmer A; Rosenquist C; Hassager C; Christiansen C
Circadian rhythm in type I collagen formation in postmenopausal women with and without osteopenia.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 1995;5(6):472-7.
1995: Riis B J; Overgaard K; Christiansen C
Biochemical markers of bone turnover to monitor the bone response to postmenopausal hormone replacement therapy.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 1995;5(4):276-80.
1994: Wang Q; Hassager C; Ravn P; Wang S; Christiansen C
Total and regional body-composition changes in early postmenopausal women: age-related or menopause-related?
The American journal of clinical nutrition 1994;60(6):843-8.
1994: Christiansen C
The different routes of administration and the effect of hormone replacement therapy on osteoporosis.
Fertility and sterility 1994;62(6 Suppl 2):152S-156S.
1994: Ravn P; Hetland M L; Overgaard K; Christiansen C
Premenopausal and postmenopausal changes in bone mineral density of the proximal femur measured by dual-energy X-ray absorptiometry.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1994;9(12):1975-80.
1994: Schlemmer A; Hassager C; Pedersen B J; Christiansen C
Posture, age, menopause, and osteopenia do not influence the circadian variation in the urinary excretion of pyridinium crosslinks.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1994;9(12):1883-8.
1994: Bonde M; Qvist P; Fledelius C; Riis B J; Christiansen C
Immunoassay for quantifying type I collagen degradation products in urine evaluated.
Clinical chemistry 1994;40(11 Pt 1):2022-5.
1994: Hetland M L; Haarbo J; Christiansen C; Larsen T
[Bone metabolism in female runners. Menstruation disorders are frequent among long-distance runners, but the bone mass is not influenced, with the exception of runners with amenorrhea]
Ugeskrift for laeger 1994;156(48):7219-23.
1994: Hassager C; Risteli J; Risteli L; Christiansen C
Effect of the menopause and hormone replacement therapy on the carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 1994;4(6):349-52.
1994: Svendsen O L; Hassager C; Christiansen C
[Physical exercise as a supplement to diet. Effect on body composition, resting metabolic rate and cardiovascular risk factors in postmenopausal overweight women]
Ugeskrift for laeger 1994;156(41):6035-8.
1994: Svendsen O L; Hassager C; Christiansen C
Six months' follow-up on exercise added to a short-term diet in overweight postmenopausal women--effects on body composition, resting metabolic rate, cardiovascular risk factors and bone.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1994;18(10):692-8.
1994: Marslew U; Munk-Nielsen N; Nilas L; Riis B J; Christiansen C
Bleeding pattern and climacteric symptoms during different sequential combined HRT regimens in current use.
Maturitas 1994;19(3):225-37.
1994: Nielsen N M; von der Recke P; Hansen M A; Overgaard K; Christiansen C
Estimation of the effect of salmon calcitonin in established osteoporosis by biochemical bone markers.
Calcified tissue international 1994;55(1):8-11.
1994: Schlemmer A; Hassager C; Delmas P D; Christiansen C
Urinary excretion of pyridinium cross-links in healthy women; the long-term effects of menopause and oestrogen/progesterone therapy.
Clinical endocrinology 1994;40(6):777-82.
1994: Fledelius C; Riis B J; Overgaard K; Christiansen C
The diagnostic validity of urinary free pyridinolines to identify women at risk of osteoporosis.
Calcified tissue international 1994;54(5):381-4.
1994: Hassager C; Jensen S B; Christiansen C
Non-responders to hormone replacement therapy for the prevention of postmenopausal bone loss: do they exist?
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 1994;4(1):36-41.
1994: Hassager C; Jensen L T; Pødenphant J; Thomsen K; Christiansen C
The carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen in serum as a marker of bone resorption: the effect of nandrolone decanoate and hormone replacement therapy.
Calcified tissue international 1994;54(1):30-3.
1994: Christiansen C
Postmenopausal bone loss and the risk of osteoporosis.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 1994;4 Suppl 1():47-51.
1993: Clemmesen B; Overgaard K; Riis B; Christiansen C
Human growth hormone and growth hormone releasing hormone: a double-masked, placebo-controlled study of their effects on bone metabolism in elderly women.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 1993;3(6):330-6.
1993: Svendsen O L; Hassager C; Christiansen C
Impact of regional and total body composition and hormones on resting energy expenditure in overweight postmenopausal women.
Metabolism: clinical and experimental 1993;42(12):1588-91.
1993: Christiansen C
Skeletal osteoporosis.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1993;8 Suppl 2():S475-80.
1993: Schlemmer A; Hassager C; Risteli J; Risteli L; Jensen S B; Christiansen C
Possible variation in bone resorption during the normal menstrual cycle.
Acta endocrinologica 1993;129(5):388-92.
1993: Hetland M L; Haarbo J; Christiansen C
Low bone mass and high bone turnover in male long distance runners.
The Journal of clinical endocrinology and metabolism 1993;77(3):770-5.
1993: Svendsen O L; Hassager C; Christiansen C
Relationships and independence of body composition, sex hormones, fat distribution and other cardiovascular risk factors in overweight postmenopausal women.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1993;17(8):459-63.
1993: Svendsen O L; Hassager C; Christiansen C
Effect of an energy-restrictive diet, with or without exercise, on lean tissue mass, resting metabolic rate, cardiovascular risk factors, and bone in overweight postmenopausal women.
The American journal of medicine 1993;95(2):131-40.
1993: Hansen M A; Overgaard K; Nielsen V A; Jensen G; Gotfredsen A; Christiansen C
[No increase in the prevalence of vertebral fractures among postmenopausal women over a 10-year period]
Ugeskrift for laeger 1993;155(31):2392-6.
1993: Overgaard K; Ravn P; Hansen M A; Christiansen C
[Salmon calcitonin in osteoporosis. The effect of intranasal application on bone mineral content and fracture frequency in postmenopausal women with manifest osteoporotic changes]
Ugeskrift for laeger 1993;155(31):2387-91.
1993: Christiansen C
[Prevention and treatment of osteoporosis. A review of different methods]
Ugeskrift for laeger 1993;155(31):2383-6.
1993: Reginster J Y; Christiansen C; Dequinze B; Deroisy R; Gaspard U; Taquet A N; Franchimont P
Effect of transdermal 17 beta-estradiol and oral conjugated equine estrogens on biochemical parameters of bone resorption in natural menopause.
Calcified tissue international 1993;53(1):13-6.
1993: Hetland M L; Haarbo J; Christiansen C; Larsen T
Running induces menstrual disturbances but bone mass is unaffected, except in amenorrheic women.
The American journal of medicine 1993;95(1):53-60.
1993: Byrjalsen I; Haarbo J; Christiansen C
Role of cigarette smoking on the postmenopausal endometrium during sequential estrogen and progestogen therapy.
Obstetrics and gynecology 1993;81(6):1016-21.
1993: Svendsen O L; Haarbo J; Hassager C; Christiansen C
Accuracy of measurements of body composition by dual-energy x-ray absorptiometry in vivo.
The American journal of clinical nutrition 1993;57(5):605-8.
1993: Hetland M L; Haarbo J; Christiansen C
[Total serum cholesterol in postmenopausal women: prediction of future levels through a simple measurement]
Ugeskrift for laeger 1993;155(7):478-81.
1993: Hassager C; Fabbri-Mabelli G; Christiansen C
The effect of the menopause and hormone replacement therapy on serum carboxyterminal propeptide of type I collagen.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 1993;3(1):50-2.
1993: Svendsen O L; Hassager C; Bergmann I; Christiansen C
Measurement of abdominal and intra-abdominal fat in postmenopausal women by dual energy X-ray absorptiometry and anthropometry: comparison with computerized tomography.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1993;17(1):45-51.
1993: Hassager C; Christiansen C
Epidemiology, biochemistry and some results with treatment of postmenopausal osteoporosis.
Wiener medizinische Wochenschrift (1946) 1993;143(14-15):389-91.
1992: Svendsen O L; Hassager C; Marslew U; Christiansen C
Changes in calcanean bone mineral occurring spontaneously and during hormone replacement therapy in early post-menopausal women.
Scandinavian journal of clinical and laboratory investigation 1992;52(8):831-6.
1992: Hassager C; Risteli J; Risteli L; Jensen S B; Christiansen C
Diurnal variation in serum markers of type I collagen synthesis and degradation in healthy premenopausal women.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1992;7(11):1307-11.
1992: Haarbo J; Christiansen C
Treatment-induced cyclic variations in serum lipids, lipoproteins, and apolipoproteins after 2 years of combined hormone replacement therapy: exaggerated cyclic variations in smokers.
Obstetrics and gynecology 1992;80(4):639-44.
1992: Overgaard K; Hansen M A; Dirksen K L; Christiansen C
Rectal salmon calcitonin for the treatment of postmenopausal osteoporosis.
Calcified tissue international 1992;51(3):184-8.
1992: Hansen M A; Hassager C; Jensen S B; Christiansen C
Is heritability a risk factor for postmenopausal osteoporosis?
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1992;7(9):1037-43.
1992: Byrjalsen I; Thormann L; Meinecke B; Riis B J; Christiansen C
Serum placental protein 14 (PP14) reflects endometrial status during hormone replacement therapy.
Human reproduction (Oxford, England) 1992;7(8):1042-7.
1992: Overgaard K; Hansen M A; Jensen S B; Christiansen C
Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study.
BMJ (Clinical research ed.) 1992;305(6853):556-61.
1992: Hansen M A; Overgaard K; Nielsen V A; Jensen G F; Gotfredsen A; Christiansen C
No secular increase in the prevalence of vertebral fractures due to postmenopausal osteoporosis.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 1992;2(5):241-6.
1992: Byrjalsen I; Thormann L; Riis B J; Christiansen C
Secretory endometrial protein PP14 in serum from post-menopausal women receiving continuous combined oestradiol-cyproterone acetate: correlation with serum hormone concentrations and bleeding patterns.
Maturitas 1992;15(1):39-46.
1992: Hassager C; Colwell A; Assiri A M; Eastell R; Russell R G; Christiansen C
Effect of menopause and hormone replacement therapy on urinary excretion of pyridinium cross-links: a longitudinal and cross-sectional study.
Clinical endocrinology 1992;37(1):45-50.
1992: Haarbo J; Svendsen O L; Christiansen C
Progestogens do not affect aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits.
Circulation research 1992;70(6):1198-202.
1992: Byrjalsen I; Thormann L; Meinecke B; Riis B J; Christiansen C
Sequential estrogen and progestogen therapy: assessment of progestational effects on the postmenopausal endometrium.
Obstetrics and gynecology 1992;79(4):523-8.
1992: Schlemmer A; Hassager C; Jensen S B; Christiansen C
Marked diurnal variation in urinary excretion of pyridinium cross-links in premenopausal women.
The Journal of clinical endocrinology and metabolism 1992;74(3):476-80.
1992: Marslew U; Overgaard K; Riis B J; Christiansen C
Two new combinations of estrogen and progestogen for prevention of postmenopausal bone loss: long-term effects on bone, calcium and lipid metabolism, climacteric symptoms, and bleeding.
Obstetrics and gynecology 1992;79(2):202-10.
1992: Overgaard K; Hansen M A; Riis B J; Christiansen C
Discriminatory ability of bone mass measurements (SPA and DEXA) for fractures in elderly postmenopausal women.
Calcified tissue international 1992;50(1):30-5.
1992: Hetland M L; Haarbo J; Christiansen C
One measurement of serum total cholesterol is enough to predict future levels in healthy postmenopausal women.
The American journal of medicine 1992;92(1):25-8.
1992: Christiansen C
Prevention and treatment of osteoporosis: a review of current modalities.
Bone 1992;13 Suppl 1():S35-9.
1992: Svendsen O L; Marslew U; Hassager C; Christiansen C
Measurements of bone mineral density of the proximal femur by two commercially available dual energy X-ray absorptiometric systems.
European journal of nuclear medicine 1992;19(1):41-6.
1991: Haarbo J; Marslew U; Gotfredsen A; Christiansen C
Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause.
Metabolism: clinical and experimental 1991;40(12):1323-6.
1991: Marslew U; Riis B J; Christiansen C
Desogestrel in hormone replacement therapy: long-term effects on bone, calcium and lipid metabolism, climacteric symptoms, and bleeding.
European journal of clinical investigation 1991;21(6):601-7.
1991: Schlemmer A; Johansen J S; Pedersen S A; Jørgensen J O; Hassager C; Christiansen C
The effect of growth hormone (GH) therapy on urinary pyridinoline cross-links in GH-deficient adults.
Clinical endocrinology 1991;35(6):471-6.
1991: Hansen M A; Overgaard K; Riis B J; Christiansen C
Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12 year study.
BMJ (Clinical research ed.) 1991;303(6808):961-4.
1991: Hassager C; Jensen S B; Gotfredsen A; Christiansen C
The impact of measurement errors on the diagnostic value of bone mass measurements: theoretical considerations.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 1991;1(4):250-6.
1991: Haarbo J; Hansen B F; Christiansen C
Hormone replacement therapy prevents coronary artery disease in ovariectomized cholesterol-fed rabbits.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 1991;99(8):721-7.
1991: Haarbo J; Gotfredsen A; Hassager C; Christiansen C
Validation of body composition by dual energy X-ray absorptiometry (DEXA).
Clinical physiology (Oxford, England) 1991;11(4):331-41.
1991: Delmas P D; Schlemmer A; Gineyts E; Riis B; Christiansen C
Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1991;6(6):639-44.
1991: Svendsen O L; Haarbo J; Heitmann B L; Gotfredsen A; Christiansen C
Measurement of body fat in elderly subjects by dual-energy x-ray absorptiometry, bioelectrical impedance, and anthropometry.
The American journal of clinical nutrition 1991;53(5):1117-23.
1991: Marslew U; Riis B J; Christiansen C
Bleeding patterns during continuous combined estrogen-progestogen therapy.
American journal of obstetrics and gynecology 1991;164(5 Pt 1):1163-8.
1991: Haarbo J; Hassager C; Jensen S B; Riis B J; Christiansen C
Serum lipids, lipoproteins, and apolipoproteins during postmenopausal estrogen replacement therapy combined with either 19-nortestosterone derivatives or 17-hydroxyprogesterone derivatives.
The American journal of medicine 1991;90(5):584-9.
1991: Haarbo J; Leth-Espensen P; Stender S; Christiansen C
Estrogen monotherapy and combined estrogen-progestogen replacement therapy attenuate aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits.
The Journal of clinical investigation 1991;87(4):1274-9.
1991: Marslew U; Riis B; Christiansen C
Progestogens: therapeutic and adverse effects in early post-menopausal women.
Maturitas 1991;13(1):7-16.
1991: Uebelhart D; Schlemmer A; Johansen J S; Gineyts E; Christiansen C; Delmas P D
Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links.
The Journal of clinical endocrinology and metabolism 1991;72(2):367-73.
1991: Hassager C; Jensen L T; Johansen J S; Riis B J; Melkko J; Pødenphant J; Risteli L; Christiansen C; Risteli J
The carboxy-terminal propeptide of type I procollagen in serum as a marker of bone formation: the effect of nandrolone decanoate and female sex hormones.
Metabolism: clinical and experimental 1991;40(2):205-8.
1991: Overgaard K; Agnusdei D; Hansen M A; Maioli E; Christiansen C; Gennari C
Dose-response bioactivity and bioavailability of salmon calcitonin in premenopausal and postmenopausal women.
The Journal of clinical endocrinology and metabolism 1991;72(2):344-9.
1991: Hansen M A; Overgaard K; Riis B J; Christiansen C
Potential risk factors for development of postmenopausal osteoporosis--examined over a 12-year period.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 1991;1(2):95-102.
1991: Christiansen C
Use of nasally administered salmon calcitonin in preventing bone loss.
Calcified tissue international 1991;49 Suppl 2():S14-5.
1991: Overgaard K; Christiansen C
Long-term treatment of established osteoporosis with intranasal calcitonin.
Calcified tissue international 1991;49 Suppl():S60-3.
1991: Johansen J S; Delmas P D; Riis B J; Gineyts E; Christiansen C
Serum-free gamma carboxyglutamic acid (free Gla) is a poor biochemical marker of bone resorption in early postmenopausal women.
Bone 1991;12(4):257-60.
1990: Hartwell D; Riis B J; Christiansen C
Comparison of vitamin D metabolism in early healthy and late osteoporotic postmenopausal women.
Calcified tissue international 1990;47(6):332-7.
1990: Christiansen C; Riis B J
Five years with continuous combined oestrogen/progestogen therapy. Effects on calcium metabolism, lipoproteins, and bleeding pattern.
British journal of obstetrics and gynaecology 1990;97(12):1087-92.
1990: Hassager C; Jensen L T; Pødenphant J; Riis B J; Christiansen C
Collagen synthesis in postmenopausal women during therapy with anabolic steroid or female sex hormones.
Metabolism: clinical and experimental 1990;39(11):1167-9.
1990: Johansen J S; Jensen S B; Riis B J; Christiansen C
Time-dependent variations in bone turnover parameters during 2 months' cyclic treatment with different doses of combined estrogen and progestogen in postmenopausal women.
Metabolism: clinical and experimental 1990;39(11):1122-6.
1990: Jensen J; Nilas L; Christiansen C
Influence of menopause on serum lipids and lipoproteins.
Maturitas 1990;12(4):321-31.
1990: Haarbo J; Hassager C; Schlemmer A; Christiansen C
Influence of smoking, body fat distribution, and alcohol consumption on serum lipids, lipoproteins, and apolipoproteins in early postmenopausal women.
Atherosclerosis 1990;84(2-3):239-44.
1990: Christiansen C; Riis B J
17 Beta-estradiol and continuous norethisterone: a unique treatment for established osteoporosis in elderly women.
The Journal of clinical endocrinology and metabolism 1990;71(4):836-41.
1990: Mathiassen B; Nielsen S; Johansen J S; Hartwell D; Ditzel J; Rødbro P; Christiansen C
Long-term bone loss in insulin-dependent diabetic patients with microvascular complications.
The Journal of diabetic complications 1990;4(4):145-9.
1990: Christiansen C; Lindsay R
Estrogens, bone loss and preservation.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 1990;1(1):7-13.
1990: Christiansen C; Riis B J; Rødbro P
Screening procedure for women at risk of developing postmenopausal osteoporosis.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 1990;1(1):35-40.
1990: Hansen M A; Riis B J; Overgaard K; Hassager C; Christiansen C
Bone mass measured by photon absorptiometry: comparison of forearm, heel, and spine.
Scandinavian journal of clinical and laboratory investigation 1990;50(5):517-23.
1990: Christiansen C; Riis B J
Hormonal replacement therapy and the skeletal system.
Maturitas 1990;12(3):247-57.
1990: Johansen J S; Jensen S B; Riis B J; Rasmussen L; Zachmann M; Christiansen C
Serum bone Gla protein: a potential marker of growth hormone (GH) deficiency and the response to GH therapy.
The Journal of clinical endocrinology and metabolism 1990;71(1):122-6.
1990: Hansen M A; Hassager C; Overgaard K; Marslew U; Riis B J; Christiansen C
Dual-energy x-ray absorptiometry: a precise method of measuring bone mineral density in the lumbar spine.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1990;31(7):1156-62.
1990: Hadberg A; Hassager C; Hildebrandt P; Christiansen C
Comparison of two immunoinhibitory methods with agarose gel-electrophoresis for measuring the MB isoenzyme of creatine kinase in serum from cases of suspected myocardial infarction.
Journal of clinical chemistry and clinical biochemistry. Zeitschrift für klinische Chemie und klinische Biochemie 1990;28(7):453-8.
1990: Schlemmer A; Hassager C; Haarbo J; Christiansen C
Direct measurement of abdominal fat by dual photon absorptiometry.
International journal of obesity 1990;14(7):603-11.
1990: Overgaard K; Hansen M A; Nielsen V A; Riis B J; Christiansen C
Discontinuous calcitonin treatment of established osteoporosis--effects of withdrawal of treatment.
The American journal of medicine 1990;89(1):1-6.
1990: Hartwell D; Riis B J; Christiansen C
Changes in vitamin D metabolism during natural and medical menopause.
The Journal of clinical endocrinology and metabolism 1990;71(1):127-32.
1990: Gotfredsen A; Riis B J; Christiansen C; Rødbro P
Does a single local absorptiometric bone measurement indicate the overall skeletal status? Implications for osteoporosis and osteoarthritis of the hip.
Clinical rheumatology 1990;9(2):193-203.
1990: Hartwell D; Hassager C; Overgaard K; Riis B J; Pødenphant J R; Christiansen C
Vitamin D metabolism in osteoporotic women during treatment with estrogen, an anabolic steroid, or calcitonin.
Acta endocrinologica 1990;122(6):715-21.
1990: Byrjalsen I; Riis B J; Christiansen C
Serum placental protein 14 in pre-menopausal and post-menopausal women--dependency on oestrogen/progestogen status.
Maturitas 1990;12(2):79-88.
1990: Schlemmer A; Jensen J; Riis B J; Christiansen C
Smoking induces increased androgen levels in early post-menopausal women.
Maturitas 1990;12(2):99-104.
1990: Hartwell D; Rødbro P; Jensen S B; Thomsen K; Christiansen C
Vitamin D metabolites--relation to age, menopause and endometriosis.
Scandinavian journal of clinical and laboratory investigation 1990;50(2):115-21.
1990: Johansen J S; Pedersen S A; Jørgensen J O; Riis B J; Christiansen C; Christiansen J S; Skakkebaek N E
Effects of growth hormone (GH) on plasma bone Gla protein in GH-deficient adults.
The Journal of clinical endocrinology and metabolism 1990;70(4):916-9.
1990: Riis B J; Christiansen C; Johansen J S; Jacobson J
Is it possible to prevent bone loss in young women treated with luteinizing hormone-releasing hormone agonists?
The Journal of clinical endocrinology and metabolism 1990;70(4):920-4.
1990: Hassager C; Pødenphant J; Iversen E; Christiansen C
Studies of soft tissue body composition using single and dual photon absorptiometry.
Basic life sciences 1990;55():219-25.
1990: Gotfredsen A; Hassager C; Christiansen C
Total and regional bone mass in healthy and osteoporotic women.
Basic life sciences 1990;55():101-6.
1989: Hassager C; Riis B J; Pødenphant J; Christiansen C
Nandrolone decanoate treatment of post-menopausal osteoporosis for 2 years and effects of withdrawal.
Maturitas 1989;11(4):305-17.
1989: Gotfredsen A; Nilas L; Pødenphant J; Hadberg A; Christiansen C
Regional bone mineral in healthy and osteoporotic women: a cross-sectional study.
Scandinavian journal of clinical and laboratory investigation 1989;49(8):739-49.
1989: Haarbo J; Hassager C; Riis B J; Christiansen C
Relation of body fat distribution to serum lipids and lipoproteins in elderly women.
Atherosclerosis 1989;80(1):57-62.
1989: Hartwell D; Johansen J S; Christiansen C
Discrepancy between serum concentrations of 1,25-dihydroxyvitamin D metabolites measured by radio-immunoassay and thymus radioreceptor assay during vitamin D2 treatment.
Scandinavian journal of clinical and laboratory investigation 1989;49(6):545-53.
1989: Hassager C; Christiansen C
Usefulness of bone mass measurements by photon absorptiometry.
Public health reports (Washington, D.C. : 1974) 1989;104 Suppl():23-6.
1989: Hassager C; Sørensen S S; Nielsen B; Christiansen C
Body composition measurement by dual photon absorptiometry: comparison with body density and total body potassium measurements.
Clinical physiology (Oxford, England) 1989;9(4):353-60.
1989: Overgaard K; Riis B J; Christiansen C; Hansen M A
Effect of salcatonin given intranasally on early postmenopausal bone loss.
BMJ (Clinical research ed.) 1989;299(6697):477-9.
1989: Hassager C; Christiansen C
Estrogen/gestagen therapy changes soft tissue body composition in postmenopausal women.
Metabolism: clinical and experimental 1989;38(7):662-5.
1989: Byrjalsen I; Riis B J; Christiansen C
The measurement of secretory endometrial protein PP14 in serum from postmenopausal women receiving unopposed estrogen or continuously combined estrogen/progestogen.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 1989;3(2):143-52.
1989: Christiansen C; Riis B J
New methods for identifying "at risk" patients for osteoporosis.
Clinical rheumatology 1989;8 Suppl 2():52-5.
1989: Hartwell D; Tjellesen L; Christiansen C; Rødbro P
Metabolism of vitamin D2 and vitamin D3 in patients on anticonvulsant therapy.
Acta neurologica Scandinavica 1989;79(6):487-92.
1989: Jensen J; Riis B J; Strøm V; Christiansen C
Long-term and withdrawal effects of two different oestrogen-progestogen combinations on lipid and lipoprotein profiles in post-menopausal women.
Maturitas 1989;11(2):117-28.
1989: Hassager C; Nielsen B; Christiansen C
Estimation of total body composition from single photon absorptiometry measurement of forearm fat content.
Scandinavian journal of clinical and laboratory investigation 1989;49(3):233-8.
1989: Nilas L; Christiansen C
The pathophysiology of peri- and postmenopausal bone loss.
British journal of obstetrics and gynaecology 1989;96(5):580-7.
1989: Overgaard K; Riis B J; Christiansen C; Pødenphant J; Johansen J S
Nasal calcitonin for treatment of established osteoporosis.
Clinical endocrinology 1989;30(4):435-42.
1989: Johansen J S; Hassager C; Pødenphant J; Riis B J; Hartwell D; Thomsen K; Christiansen C
Treatment of postmenopausal osteoporosis: is the anabolic steroid nandrolone decanoate a candidate?
Bone and mineral 1989;6(1):77-86.
1989: Gotfredsen A; Pødenphant J; Nilas L; Christiansen C
Discriminative ability of total body bone-mineral measured by dual photon absorptiometry.
Scandinavian journal of clinical and laboratory investigation 1989;49(2):125-34.
1989: Hassager C; Pødenphant J; Riis B J; Johansen J S; Jensen J; Christiansen C
Changes in soft tissue body composition and plasma lipid metabolism during nandrolone decanoate therapy in postmenopausal osteoporotic women.
Metabolism: clinical and experimental 1989;38(3):238-42.
1989: Hassager C; Borg J; Christiansen C
Measurement of the subcutaneous fat in the distal forearm by single photon absorptiometry.
Metabolism: clinical and experimental 1989;38(2):159-65.
1989: Hassager C; Christiansen C
Influence of soft tissue body composition on bone mass and metabolism.
Bone 1989;10(6):415-9.
1988: Pødenphant J; Riis B J; Johansen J S; Leth A; Christiansen C
Iliac crest biopsy in longitudinal therapeutic trials of osteoporosis.
Bone and mineral 1988;5(1):77-87.
1988: Nilas L; Christiansen C
Rates of bone loss in normal women: evidence of accelerated trabecular bone loss after the menopause.
European journal of clinical investigation 1988;18(5):529-34.
1988: Jensen J; Christiansen C
Effects of smoking on serum lipoproteins and bone mineral content during postmenopausal hormone replacement therapy.
American journal of obstetrics and gynecology 1988;159(4):820-5.
1988: Johansen J S; Riis B J; Hassager C; Moen M; Jacobson J; Christiansen C
The effect of a gonadotropin-releasing hormone agonist analog (nafarelin) on bone metabolism.
The Journal of clinical endocrinology and metabolism 1988;67(4):701-6.
1988: Johansen J S; Giwercman A; Hartwell D; Nielsen C T; Price P A; Christiansen C; Skakkebaek N E
Serum bone Gla-protein as a marker of bone growth in children and adolescents: correlation with age, height, serum insulin-like growth factor I, and serum testosterone.
The Journal of clinical endocrinology and metabolism 1988;67(2):273-8.
1988: Riis B J; Johansen J; Christiansen C
Continuous oestrogen-progestogen treatment and bone metabolism in post-menopausal women.
Maturitas 1988;10(1):51-8.
1988: Riis B J; Christiansen C
Measurement of spinal or peripheral bone mass to estimate early postmenopausal bone loss?
The American journal of medicine 1988;84(4):646-53.
1988: Nilas L; Gotfredsen A; Hadberg A; Christiansen C
Age-related bone loss in women evaluated by the single and dual photon technique.
Bone and mineral 1988;4(1):95-103.
1988: Johansen J S; Riis B J; Delmas P D; Christiansen C
Plasma BGP: an indicator of spontaneous bone loss and of the effect of oestrogen treatment in postmenopausal women.
European journal of clinical investigation 1988;18(2):191-5.
1988: Hartwell D; Christiansen C
Comparisons between two receptor assays for 1,25-dihydroxyvitamin D.
Scandinavian journal of clinical and laboratory investigation 1988;48(2):109-14.
1988: Hassager C; Christiansen C
Blood pressure during oestrogen/progestogen substitution therapy in healthy post-menopausal women.
Maturitas 1988;9(4):315-23.
1988: Nilas L; Hassager C; Christiansen C
Long-term precision of dual photon absorptiometry in the lumbar spine in clinical settings.
Bone and mineral 1988;3(4):305-15.
1988: Gotfredsen A; Pødenphant J; Nørgaard H; Nilas L; Nielsen V A; Christiansen C
Accuracy of lumbar spine bone mineral content by dual photon absorptiometry.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1988;29(2):248-54.
1988: Overgaard K; Nilas L; Johansen J S; Christiansen C
Lack of seasonal variation in bone mass and biochemical estimates of bone turnover.
Bone 1988;9(5):285-8.
1988: Christiansen C
Intranasal calcitonin for prevention and treatment of osteoporosis.
Annales chirurgiae et gynaecologiae 1988;77(5-6):229-34.
1987: Pødenphant J; Johansen J S; Thomsen K; Riis B J; Leth A; Christiansen C
Bone turnover in spinal osteoporosis.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1987;2(6):497-503.
1987: Jensen J; Christiansen C
Dose-response effects on serum lipids and lipoproteins following combined oestrogen-progestogen therapy in post-menopausal women.
Maturitas 1987;9(3):259-66.
1987: Jensen P B; Jensen J; Riis B J; Rødbro P; Strøm V; Christiansen C
Climacteric symptoms after oral and percutaneous hormone replacement therapy.
Maturitas 1987;9(3):207-15.
1987: Nilas L; Christiansen C
Bone mass and its relationship to age and the menopause.
The Journal of clinical endocrinology and metabolism 1987;65(4):697-702.
1987: Hassager C; Riis B J; Strøm V; Guyene T T; Christiansen C
The long-term effect of oral and percutaneous estradiol on plasma renin substrate and blood pressure.
Circulation 1987;76(4):753-8.
1987: Thomsen K; Riis B J; Johansen J S; Christiansen C; Rødbro P
Bone turnover in postmenopausal women after withdrawal of estrogen/gestagen replacement therapy.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 1987;1(2):169-75.
1987: Thomsen K; Rødbro P; Christiansen C
Bone turnover determined by urinary excretion of [99mTc]diphosphonate in the prediction of postmenopausal bone loss.
Bone and mineral 1987;2(2):125-31.
1987: Riis B J; Jensen J; Christiansen C
Cyproterone acetate, an alternative gestagen in postmenopausal oestrogen/gestagen therapy.
Clinical endocrinology 1987;26(3):327-34.
1987: Jensen J; Riis B J; Strøm V; Christiansen C
Continuous oestrogen-progestogen treatment and serum lipoproteins in postmenopausal women.
British journal of obstetrics and gynaecology 1987;94(2):130-5.
1987: Nilas L; Nørgaard H; Pødenphant J; Gotfredsen A; Christiansen C
Bone composition in the distal forearm.
Scandinavian journal of clinical and laboratory investigation 1987;47(1):41-6.
1987: Riis B J; Nilas L; Christiansen C
Does calcium potentiate the effect of estrogen therapy on postmenopausal bone loss?
Bone and mineral 1987;2(1):1-9.
1987: Jensen J; Riis B J; Strøm V; Nilas L; Christiansen C
Long-term effects of percutaneous estrogens and oral progesterone on serum lipoproteins in postmenopausal women.
American journal of obstetrics and gynecology 1987;156(1):66-71.
1987: Riis B J; Thomsen K; Strøm V; Christiansen C
The effect of percutaneous estradiol and natural progesterone on postmenopausal bone loss.
American journal of obstetrics and gynecology 1987;156(1):61-5.
1987: Pøodenphant J; Nielsen V A; Riis B J; Gotfredsen A; Christiansen C
Bone mass, bone structure and vertebral fractures in osteoporotic patients.
Bone 1987;8(3):127-30.
1987: Hartwell D; Riis B J; Christiansen C; Thomsen K; Johansen J S; Rødbro P
Bone metabolism and bone status in osteoporotic patients.
Acta medica Scandinavica 1987;222(5):453-8.
1986: Nilas L; Gotfredsen A; Riis B J; Christiansen C
The diagnostic validity of local and total bone mineral measurements in postmenopausal osteoporosis and osteoarthritis.
Clinical endocrinology 1986;25(6):711-20.
1986: Thomsen K; Riis B; Christiansen C
Effect of estrogen/gestagen and 24R,25-dihydroxyvitamin D3 therapy on bone formation in postmenopausal women.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1986;1(6):503-7.
1986: Tjellesen L; Hummer L; Christiansen C; Rødbro P
Serum concentration of vitamin D metabolites during treatment with vitamin D2 and D3 in normal premenopausal women.
Bone and mineral 1986;1(5):407-13.
1986: Pødenphant J; Gotfredsen A; Nilas L; Nørgård H; Braendstrup O; Christiansen C
Iliac crest biopsy: an investigation on certain aspects of precision and accuracy.
Bone and mineral 1986;1(4):279-87.
1986: Gotfredsen A; Riis B J; Christiansen C
Total and local bone mineral during estrogen treatment: a placebo controlled trial.
Bone and mineral 1986;1(2):167-73.
1986: Tjellesen L; Hummer L; Christiansen C; Rødbro P
Different metabolism of vitamin D2/D3 in epileptic patients treated with phenobarbitone/phenytoin.
Bone 1986;7(5):337-42.
1985: Hummer L; Christiansen C; Tjellesen L
Discrepancy between serum 1,25-dihydroxycholecalciferol measured by radioimmunoassay and cytosol radioreceptor assay.
Scandinavian journal of clinical and laboratory investigation 1985;45(8):725-33.
1985: Hummer L; Riis B J; Christiansen C; Rickers H
Determination of mono- and dihydroxy-vitamin D metabolites in normal subjects and patients with different calcium metabolic diseases.
Scandinavian journal of clinical and laboratory investigation 1985;45(7):611-9.
1985: Tjellesen L; Christiansen C; Rødbro P; Hummer L
Different metabolism of vitamin D2 and vitamin D3 in epileptic patients on carbamazepine.
Acta neurologica Scandinavica 1985;71(5):385-9.
1984: Hummer L; Tjellesen L; Rickers H; Christiansen C
Measurement of 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 in clinical settings.
Scandinavian journal of clinical and laboratory investigation 1984;44(7):595-601.
1984: Hummer L; Nilas L; Tjellesen L; Christiansen C
A selective and simplified radioimmunoassay of 25-hydroxyvitamin D3.
Scandinavian journal of clinical and laboratory investigation 1984;44(2):163-7.
1983: Tjellesen L; Christiansen C; Hummer L; Larsen N E
Unchanged biochemical indices of bone turnover despite fluctuations in 1,25-dihydroxyvitamin D during the menstrual cycle.
Acta endocrinologica 1983;102(3):476-80.

Sign-in to see more